94 related articles for article (PubMed ID: 8103389)
1. Derivatives of 1,2-diazetidine-1,2-di-N-oxides--a new class of soluble guanylate cyclase activators with vasodilatory properties.
Severina IS; Ryaposova IK; Volodarsky LB; Mozhuchin DC; Tichonov AYa ; Schwartz GYa ; Granik VG; Grigoryev DA; Grigoryev NB
Biochem Mol Biol Int; 1993 Jun; 30(2):357-66. PubMed ID: 8103389
[TBL] [Abstract][Full Text] [Related]
2. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
Riaposova IK; Grigor'ev NV; Severina IS
Biokhimiia; 1994 Apr; 59(4):537-42. PubMed ID: 7912551
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
[TBL] [Abstract][Full Text] [Related]
5. [The role of thiols in the stimulation of soluble guanylate cyclase by a new class of enzyme activators generating nitric oxide].
Belushkina NN; Riaposova IK; Severina IS
Biull Eksp Biol Med; 1997 Jan; 123(1):39-42. PubMed ID: 9213454
[No Abstract] [Full Text] [Related]
6. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
[TBL] [Abstract][Full Text] [Related]
7. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of activation of soluble guanylate cyclase by guanidine thiols--a new class of enzyme activators.
Severina IS; Bussygina OG; Vinograd LH; Grigoryev NB
Biochem Mol Biol Int; 1996 Mar; 38(3):509-18. PubMed ID: 8829610
[TBL] [Abstract][Full Text] [Related]
10. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
11. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
Severina IS
Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
[No Abstract] [Full Text] [Related]
12. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of organic nitrates for activation of guanylate cyclase.
Schröder H; Noack E
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):235-46. PubMed ID: 2895614
[TBL] [Abstract][Full Text] [Related]
14. [The role of SH-groups in guanidine thiols--new substrates for NO-synthase--in stimulating the activity of guanylate cyclase].
Busygina OG; Grigor'ev NB; Severina IS
Biokhimiia; 1996 Jan; 61(1):119-25. PubMed ID: 8679771
[TBL] [Abstract][Full Text] [Related]
15. Effect of nitroso complexes of some transition metals on the activity of soluble guanylate cyclase.
Severina IS; Bussygina OG; Grigorjev NB
Biochem Int; 1992 Mar; 26(4):695-705. PubMed ID: 1351725
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
17. [The activation of soluble guanylate cyclase by new NO donors as the basis of a directed search for new efficacious vasodilators and antiaggregants].
Severina IS; Bussygina OG; Piatakova NV
Vestn Ross Akad Med Nauk; 2000; (4):25-30. PubMed ID: 10832410
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble guanylate cyclase in reactivation of choline esterase inhibited by phosphoorganic compounds.
Pyatakova NV; Grigoryev NB; Severina IS
Biochemistry (Mosc); 1999 Jan; 64(1):91-4. PubMed ID: 9986919
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
20. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase.
Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA
Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
